Palisade Bio Inc (PALI) — Institutional Holders Breakdown (Q2 2026)

PALI ranks #4076 out of 37503 tracked stocks by institutional interest, inside the more closely watched half of our coverage.

PALI is a top-conviction position for B Group, Inc. — at 11.2% of their entire disclosed 13F portfolio, it's one of their largest single bets, not just a passing allocation.

The largest dollar stake in PALI belongs to Soleus Capital Management, L.P., but the position matters far more to B Group, Inc., who has 11.2% of their own portfolio riding on it — a reminder that the biggest holder by size and the holder with the biggest bet aren't always the same fund.

B Group, Inc. has added to its PALI position for two straight quarters, increasing it by $13.3M to reach $23.9M today.

Morgan Stanley has trimmed its PALI position for two straight quarters, cutting it by $4.6M while still holding $5.2M.

PALI is up 0.5% today, and institutions have been net buyers of $71.0M this quarter — today's price move and the underlying institutional flow are pointing the same direction.

PALI reported a net loss of $31.9M over the trailing twelve months.

• Not yet profitable — net loss of $31.9M over the trailing twelve months
• Net income declined year over year, from -$11.8M to -$31.9M
• Operating cash flow was negative, using $10.8M in cash
• Current ratio of 28.95x — enough short-term assets to cover short-term liabilities
• Liabilities run 0.04x equity — within a conventional range